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In the remaining three patients who had a normal swallow, but in whom E. sakazakii was found in the oral cavity, two received active SDD gel and one placebo, with no evidence of a pneumonic process or septicaemia. In the report of See and colleagues [1] , the bacterium was resistant to cephalexin. In our 10 oral isolates, all except one was resistant to ampicillin, one was resistant to tobramycin, three to colistin, four to cephotaxime, four to trimethopin and three to ciprofloxacin. In the case report, the 75-year-old woman deteriorated after an initial clinical response, with the authors surmising that the organism had developed cephalosporin resistance. In one of our patients, in whom E. sakazakii was isolated on four separate occasions, we found that the antibiotic sensitivities altered, probably as a result of the SDD gel.
We would like to speculate that the patient may have had oral colonisation with E. sakazakii, which subsequently resulted in a pneumonia complicated by a splenic abscess. We agree with the authors that E. sakazakii should not be treated with a cephalosporin and that E. sakazakii must be considered in older individuals who fail to respond to traditional antibiotic administration.
We hope that, by highlighting a possible pathogenesis of the E. sakazakii splenic abscess, clinicians caring for older individuals with impaired oral hygiene and abnormal swallow or immunosuppression due to age, disease or treatment, will consider E. sakazakii as an aetiological agent if early treatment fails to result in a clinical response. Colleagues from several disciplines working in Memory Services across the West Midlands felt alarmed by the drift of the arguments presented by these respected colleagues. We would caution against adopting their conclusion that: 'There is need to stop providing dementia services across multiple agencies. ' Their assertion that '. . . there are no integrated dementia services in the United Kingdom . . .' is false. We all work in integrated services which engage with appropriate resources across a range of agencies. This, we believe to be entirely appropriate. The alternative which Bullock et al. espouse is a segregated or exclusive service-setting apart people with dementia as a special or sub-population who will receive all their needs as subservient to their dementia label.
MARGOT GOSNEY
Contrast this with the direction of services for people with life-long learning disability, where the thrust is all toward 'normalisation' to ensure that individuals receive a proper share of expert help from across the complex range of health and social care [3] . This leaves the experts in learning disability (or dementia) to work effectively to inform, educate and support all parties to gain optimal care for every individual. We commend this approach and hope that it will be advanced through initiatives which the government is contemplating in response to the several reports published recently, and quoted helpfully by Bullock et al.
The need is to improve the quality and capacity of services for people with dementia across multiple agencies.
